Attention-deficit Hyperactivity Disorder Clinical Trial
Official title:
Prospective Follow-Up Observational Study to Examine the Progression of ADHD Drug Treatment and to Analyze Associated Factors
The purpose of this observational study is to explore the efficacy of methylphenidate hydrochloride in children and adolescents diagnosed with attention-deficit hyperactivity disorder (ADHD) by Kiddie-scheduled for affective disorders (SADS)-present and life time version (K-SADS-PL).
This is a 1-year open-label (all people involved know the identity of the assigned drug), multicenter, single arm, prospective, observational study to explore under natural setting the efficacy of drug treatment in children and adolescents diagnosed with ADHD by K-SADS-PL (K-SADS-PL is a tool used for ADHD diagnosis. Patient may be diagnosed with ADHD by using K-SADS-PL to check if he or she meets the criteria according to Diagnostic and Statistical Manual of Mental Disorders & edition (DSM-IV). After obtaining informed consent, investigator will prescribe stimulant or non-stimulant ADHD treatment medications (ie, Immediate release [IR]/extended release [ER]/osmotic release oral system (OROS) methylphenidate, atomoxetine). Efficacy and safety assessments will be performed at 4, 12, 24, 36, and 52 weeks after the first day of giving study drug. Progression of symptom improvement and adherence will be investigated and associated variables (ie, demographic, clinical, familial and treatment factors) will be analyzed. ;
Observational Model: Case-Only, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02827188 -
Cognitive Restructuring in ADHD: Functional Training
|
N/A | |
| Recruiting |
NCT05374187 -
Efficacy of Trigeminal Nerve Stimulation for ADHD
|
N/A | |
| Enrolling by invitation |
NCT04229251 -
Online Mindfulness-Based Intervention for ADHD
|
N/A | |
| Completed |
NCT00339729 -
Johnston County ADHD Study: Environmental, Reporductive, and Familial Risk Factors for Attention-Deficit Hyperactivity Disorder (ADHD)
|
N/A | |
| Completed |
NCT04416360 -
Autism Spectrum Disorder or Attention Deficit Hyperactivity Disorder in Covid-19 Outbreak
|
N/A | |
| Recruiting |
NCT01657721 -
Working Memory Training in ADHD (The Engage Study)
|
Phase 1 | |
| Completed |
NCT04786730 -
A Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Centanafadine Capsules in Pediatric Subjects With Attention-deficit Hyperactivity Disorder
|
Phase 1 | |
| Completed |
NCT01323192 -
An Efficacy and Safety Study for JNS001 in Adults With Attention-Deficit Hyperactivity Disorder
|
Phase 3 | |
| Recruiting |
NCT05165511 -
Families, Responsibility, Education, Support, and Health for Executive Function
|
N/A | |
| Completed |
NCT01886469 -
A Phase II, Adaptive Trial Design Examining the Pharmacokinetic and Pharmacodynamic Effects of Modified Release Amphetamine (HLD100, Formulations B, C and E)) in Adolescents and Children With Attention-Deficit Hyperactivity Disorder (ADHD)
|
Phase 1/Phase 2 | |
| Completed |
NCT01010750 -
Lisdexamfetamine Dimesylate (LDX) Pilot Cognition Study to Evaluate the Utility of a Standardized Battery of Tests in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)
|
Phase 1 | |
| Recruiting |
NCT04729439 -
Technology-Enhanced Executive Functioning Intervention for ADHD
|
Phase 1 | |
| Completed |
NCT03806946 -
Impact of Relationship of Epilepsy and Attention Deficit Hyperactive Disorder
|
||
| Recruiting |
NCT05869253 -
The Efficacy of Equine Assisted Occupational Therapy, for Children With Attention Deficit Hyperactivity Disorder (ADHD) on Cognitive-emotional Aspects, Daily Function and Participation
|
N/A | |
| Completed |
NCT01907360 -
Pharmacokinetics of HLD200 in Children and Adolescents With ADHD
|
Phase 1/Phase 2 |